Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISTH 2022 | Offering personalized therapy to young and elderly patients with non-severe hemophilia

Oliver Königsbrügge • 12 Jul 2022
ISTH 2022
Hemophilia

Oliver Königsbrügge, MD, PhD, Medical University of Vienna, Vienna, Austria, emphasizes the importance of selecting appropriate treatments for both young and elderly patients with non-severe hemophilia, commenting on the role of age in treatment decisions. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.

More from Oliver Königsbrügge

2:17
Obesity & arthropathy in patients with non-severe hemophilia
Oliver Königsbrügge • 12 Jul 2022

Related Videos

1:08
The current landscape of hemophilia treatment: an update from ASH 2023
Glaivy Batsuli • 10 Dec 2023
1:18
Unmet needs in hemophilia treatment
Glaivy Batsuli • 10 Dec 2023
1:11
Improving outcomes for hemophilia patients through the implementation of gene therapies
Evelien Krumb • 12 Dec 2023
1:27
The impact of emicizumab on the hemophilia treatment landscape
Glaivy Batsuli • 10 Dec 2023
The content of VJHemOnc is intended for healthcare professionals